Suburban Research Associates is seeking adults living with Type 2 diabetes who have been diagnosed with diabetes-related kidney damage and are currently managing their condition but may still have signs of kidney disease progression.
Diabetic Kidney Disease
Age Range:
18 to 80
Gender:
Male and Female
Location:
West Chester, Pennsylvania
About the Study
This research study is evaluating an investigational treatment to see if it may help protect kidney health in adults who have diabetes-related kidney disease, also known as diabetic kidney disease. This study is testing whether blocking a protein in the body may help reduce protein loss in the urine, slow the progression of kidney disease, and support overall kidney function
Qualifications
You may qualify for this study if you:
- Are 18 to 80 years old
- Have Type 2 diabetes
- Have been diagnosed with diabetic kidney disease
- Have evidence of kidney damage
- Have mild to moderate reduced kidney function
- Have an A1C between 6.5% and 10%
- Are taking stable medications for diabetes and kidney protection (such as ACE inhibitors or ARBs), or cannot tolerate them
You would not be eligible if your kidney disease is caused by something other than diabetes, if you have required dialysis or a kidney transplant, or if you have certain serious or unstable medical conditions.
* Other requirements may apply during screening process
FEATURED STUDIES
MDD Study
Adults 18 to 65 years of age with Major Depressive Disorder (MDD) may qualify for a clinical research study evaluating
Asthma
Adults and adolescents 12 years of age and older living with asthma may qualify for a clinical research study evaluating
Chronic Obstructive Pulmonary Disease (COPD)
Adults 40–75 who have COPD and experienced a flare-up in the past year may qualify for a study evaluating an
Post-Traumatic Stress Disorder (PTSD)
Adults 18 and older living with post-traumatic stress disorder (PTSD) may qualify for a clinical research study evaluating an investigational
Bronchiectasis
Individuals with bronchiectasis who experience frequent flare-ups or ongoing respiratory symptoms may qualify for a research study evaluating a home
Hypertension & Type 2 Diabetes
Researchers are studying an investigational medication to see how effective it may be in reducing risk of heart failure for